Change notification no 9 - treatment for high blood pressure
Date of publication: 24th April 2006 Implementation: To be determined by each Service Change Notification UK National Blood Services No. 9 - 2006 Appendix 5 – Treatment for High Blood Pressure Applies to Tissue Donor Selection Guidelines – Bone Marrow and PBSC Appendix 6 – Treatment for High Blood Pressure Applies to Donor Selection Guidelines - Whole Blood and Components
The entry in both the guidelines is the same:
Treatment for High Blood Pressure
Donors who have been diagnosed with high blood pressure may donate provided that:
1. They have not suffered any adverse effects of raised blood pressure (BP) such as heart disease
(angina, heart attack or heart failure), stroke, transient ischaemic attack (TIA or mini-stroke), orperipheral vascular disease (intermittent claudication, gangrene).
2. They are taking only a Beta(ß)-blocker and/or diuretic as their treatment for the raised BP. The
list below shows the proper and trade names of allowed drugs. It is important to note that this list is not exclusive and that these drugs may be used to treat other conditions such as heart failure and abnormal heart rhythms (arrhythmia); both of which would mean the donor must not donate. Other medication should be assessed independently.
That the donor is well and not having any problems with feeling faint, fainting or giddiness. They have been on the same dose of medication for at least a month. They are not undergoing tests to find out the underlying cause of their raised BP. Joint UKBTS/NIBSC Professional Advisory Committee (JPAC) JPAC Office National Blood Service, Sheffield Centre Tel: 0114 203 4903 Longley Lane Fax: 0114 203 4893 SHEFFIELD Email: email@example.com
If in any doubt check the BNF to see which class of drug is being used to treat the high BP or refer toa Designated Medical Officer.
NB. Alpha(a)-blockers are not ß-blockers and at present donors treated with a-blockers must not be bled.
Comments and corrections to firstname.lastname@example.org (24/08/05)
Dr Brian McClelland Professional Director - Joint UKBTS/NIBSC Professional Advisory Committee
( Direct Dial: (0131) 536 6002 * E-mail: Brian.McClelland@snbts.csa.scot.nhs.uk
Joint UKBTS/NIBSC Professional Advisory Committee (JPAC) JPAC Office National Blood Service, Sheffield Centre Tel: 0114 203 4903 Longley Lane Fax: 0114 203 4893 SHEFFIELD Email: email@example.com
HALTING SSRIs DAVID HEALY MD FRCPsych N WALES DEPT of PSYCHOLOGICAL MEDICINE SSRI stands for selective serotonin reuptake inhibitor. This does not meanthese drugs are selective to the serotonin system or that they are in somesense pharmacological y “clean”. It means they have little effects on thenorepinephrine/noradrenaline system. There are 8 Serotonin reuptakeVenlafaxine in dos
Powstanie programu transplantacji serca w Poznaniu 1. Wprowadzenie W roku 2010 wykonano ³¹cznie w naszym kraju 79 przeszczepów serca. Obecnie na te-renie Polski dzia³a piêæ oœrodków transplantacyjnych: najstarszy, na po³udniu – oœro-dek w Zabrzu, drugi – w Krakowie, na pó³nocy – oœrodek gdañski, w centralnej Polsce– oœrodek warszawski, a na zachodzie – nowopowsta³y,